Get the Stockscreener App
0.2925
5.98%
-0.0186
After Hours:
.29
-0.0025
-0.85%
Why is Cara Therapeutics Inc (CARA) Stock down?
We've noticed a 5.98% decline in Cara Therapeutics Inc (CARA) stock during the 2024-11-18 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
18 Dec, 2023:
Shares of Cara Therapeutics Inc (CARA) dropped by 48.85% from $1.23 to $0.6291 in the trading on Monday, December 18, 2023. The reason why CARA down today is due to the outcome from Part A of the KIND 1 study, where oral difelikefalin, as an adjunct therapy to topical corticosteroids (TCS) for moderate-to-severe pruritus in adults with atopic dermatitis (AD), did not show a meaningful clinical benefit compared to TCS alone. As a result, Cara Therapeutics has decided to discontinue its clinical program in pruritus associated with atopic dermatitis.
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):